Diagnostic Criteria and Phenotypes of Pemphigoid and the Association With Gliptins

In this issue, there are 2 excellent large retrospective studies from single centers in Groningen, The Netherlands, and Haifa, Israel of patients referred for possible bullous pemphigoid (BP). In addition, there is a nationwide population-based study from Korea evaluating the risk of BP in patients with diabetes receiving dipeptidyl peptidase 4 inhibitors (gliptins).

http://bit.ly/2slYT25